SCHEMBL6961685

SCHEMBL6961685

Cc1ccc(S(=O)(=O)S)cc1CC1CCCCC1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.39
CEL P19835 1/20 0.36
CNR2 P34972 4/20 0.36
CNR1 P21554 3/20 0.36
TDP1 Q9NUW8 3/20 0.35
KMT2A Q03164 2/20 0.35
PSEN1 P49768 1/20 0.35
PSEN2 P49810 1/20 0.35
APH1B Q8WW43 1/20 0.35
NCSTN Q92542 1/20 0.35
APH1A Q96BI3 1/20 0.35
PSENEN Q9NZ42 1/20 0.35
TSHR P16473 2/20 0.35
CYP3A4 P08684 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
GAA P10253 1/20 0.35
HTT P42858 1/20 0.34
MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6952509 0.92 ALDH1A1 (0.36) ALDH1A1CNR2TDP1KMT2ASMN1; SMN2
SCHEMBL7735410 0.84 ALDH1A1 (0.40) ALDH1A1CNR2CNR1TDP1KMT2A
SCHEMBL6961692 0.83 ALDH1A1 (0.38) ALDH1A1CELCNR2CNR1TDP1
SCHEMBL16191278 0.76 TAAR1 (0.44) ALDH1A1CELCNR1KMT2AGAA
SCHEMBL6952517 0.75 ALDH1A1 (0.35) ALDH1A1CNR2TDP1KMT2ATSHR
SCHEMBL17536382 0.74 CEL (0.38) CELKMT2AMEN1
SCHEMBL30921632 0.74 CEL (0.38) CELKMT2AMEN1
SCHEMBL18561583 0.73 SLC6A4 (0.40) CELCNR1TDP1KMT2ATSHR
SCHEMBL7846676 0.72 PIK3CD (0.35) ALDH1A1PSEN1PSEN2APH1BNCSTN
SCHEMBL21991153 0.72 PPM1D (0.36) ALDH1A1CELCNR2CNR1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed